About Osiris
Osiris is a company based in Baltimore (United States) founded in 1992 was acquired by Smith & Nephew in March 2019. The company has 356 employees as of December 31, 2018. Osiris operates in a competitive market with competitors including Horizon Therapeutics, Histogenics, Mesoblast, Osteal Therapeutics and Enobia Pharma, among others.
- Headquarter Baltimore, United States
- Employees 356 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Osiris Therapeutics, Inc.
-
Annual Revenue
$142.82 M (USD)21as on Dec 31, 2018
-
Net Profit
Not available
-
EBITDA
$9.85 M (USD)595as on Dec 31, 2018
-
Latest Funding Round
Not available
- Investors
-
Employee Count
356
as on Dec 31, 2018
-
Acquired by
Smith & Nephew
(Mar 12, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Osiris
Unlock access to complete
Funding Insights of Osiris
Detailed funding history for Osiris
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Osiris
Osiris has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Smith & Nephew.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of knee, hip and shoulder joint replacements
|
Locked | Locked | Locked |
Investor details for Osiris
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Osiris
Investment portfolio details for Osiris
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Osiris
Detailed financials for Osiris
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Osiris Comparisons
Peer comparison for Osiris
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Osiris
Osiris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Histogenics, Mesoblast, Osteal Therapeutics and Enobia Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drugs for treating rare and autoimmune diseases
|
|
| Locked | Locked | Locked |
Restorative cell therapies for orthopedic diseases are developed.
|
|
| Locked | Locked | Locked |
Biotherapeutics derived from proprietary adult stem cell-based technologies
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections
|
|
| Locked | Locked | Locked |
Therapies for genetic metabolic bone disorders are developed.
|
|
| Locked | Locked | Locked |
Cellular therapeutics are developed for cancer, orthopaedics, and COPD.
|
Detailed competitors of Osiris
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Osiris
Complete news archive for Osiris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Osiris
Osiris was founded in 1992.
Osiris is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
As of Dec 31, 2018, the latest employee count at Osiris is 356.
Annual revenue of Osiris is $142.82M as on Dec 31, 2018.
Osiris Therapeutics was founded in 1992 in Baltimore, United States, based on stem cell technology from Case Western Reserve University. Operations focus on biotechnology within regenerative medicine, including bioengineering and viable tissue products. Commercial products such as BIO4, Cartiform, and Grafix are provided for orthopaedics, sports medicine, and wound care. Research and development continue to advance stem cell applications.
Osiris's top competitors include Horizon Therapeutics, RoosterBio and Mesoblast.
Osiris has 1 investor. Key investors include Smith & Nephew.